Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

215 search results for ‘*’

Diagnostics Liquid biopsy

Fine-Tuning Immunotherapy

| George Karlin-Neumann

Techniques like droplet digital PCR technology can assist with early monitoring of cancer immunotherapy to ensure the right treatment for each patient

Outside the Lab Profession

The Spice of Life

| Luke Turner

Genomic research has a diversity problem that could restrict the future effectiveness of precision medicine for minority groups

Outside the Lab Training and education

#MedEd Goes Social

| Michael Schubert

The winners of the 2019 Educational Pathology Tweet Award share their views on the future of education in pathology and laboratory medicine.

Inside the Lab Liquid biopsy

CTCs in a Spin

| Luke Turner

A microfluidic device reveals new insights into the function of circulating tumor cells, providing vital information on how cancers metastasize.

Inside the Lab Pathologists’ assistants

The Evolution of a Lab Hero

| Jesse McCoy

Jesse McCoy explains what pathologists’ assistants do, where they come from, and how they serve as integral members of the laboratory medicine team

Inside the Lab Technology and innovation

HIER, Further, Faster

| Jason Ramos, Spontaneous Russell

Automated IHC staining has limited capacity for heat-induced epitope retrieval – but a move to hybrid power lifts that barrier.

Outside the Lab Profession

Know Your Strength

| Michael Schubert

A panel of women experts in pathology and lab medicine answer questions about gender-specific career issues.

Diagnostics Biochemistry and molecular biology

A Disease With Many Faces

| David R. Hout

Triple-negative breast cancer is not a single entity, and understanding each patient’s molecular subtype can influence treatment and outcomes

Inside the Lab Clinical care

Under Pressure

| Will Culliford

How can diagnostic technologies help ease the increased healthcare pressures of the winter months?

Inside the Lab Precision medicine

Next-Generation Sequencing: Will It Really Replace Single-Gene Tests in Pathology Labs?

| Sponsored by Thermo Fisher Scientific

The move to in-house next-generation sequencing has resulted in time and tissue savings, and improved collaboration across cancer care specialties

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register